2021
DOI: 10.1177/1756286420975642
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study

Abstract: Background: Therapeutic plasma exchange (TPE) is frequently used in glucocorticosteroid (GCS)-refractory multiple sclerosis (MS) relapses. Data regarding predictors of treatment response are scarce. The objective of this study was to analyze predictive factors for response to TPE in GCS-refractory MS patients. Methods: A total of 118 MS patients in two tertiary MS centers were analyzed. Primary outcome was TPE response defined as marked, mild, or no improvement. Secondary outcome was change in expanded disabil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 25 publications
1
8
0
Order By: Relevance
“…In practice, MS patients may be wrongly mixed with other white matter disorders, e.g., neuromyelitis optica (Sousa et al, 2021), acute disseminated encephalomyelitis, acute cerebral infarction (Moreno-Andrade et al, 2021), etc. Consequently, error-free MS diagnosis is of extreme significance to patients, as they can be allowed more time to decide on the subsequent treatments to help control the condition, such as treating relapses (Hartung et al, 2021) with short courses of steroid medicine (Blechinger et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…In practice, MS patients may be wrongly mixed with other white matter disorders, e.g., neuromyelitis optica (Sousa et al, 2021), acute disseminated encephalomyelitis, acute cerebral infarction (Moreno-Andrade et al, 2021), etc. Consequently, error-free MS diagnosis is of extreme significance to patients, as they can be allowed more time to decide on the subsequent treatments to help control the condition, such as treating relapses (Hartung et al, 2021) with short courses of steroid medicine (Blechinger et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Plasma exchange is effective in antibody-mediated neurological diseases, such as GBS, and in the treatment of acute exacerbation of neuroimmunological diseases, in which it can yield rapid clinical improvements 80 82 . The response to vaccines administered during plasma exchange for neuroimmunological diseases has not been studied systematically.…”
Section: Immunotherapy and Vaccination Responsementioning
confidence: 99%
“…The first choice for the treatment of acute relapses is glucocorticoids. In the case of steroid-refractory relapses, an escalating therapy with apheresis may be indicated [48,49]. In the past years, a wide range of disease-modifying treatments for MS have been approved to prevent new lesions, reduce the frequency of relapses and slow down the rate of disability worsening [50].…”
Section: Multiple Sclerosismentioning
confidence: 99%